Efficacy of risperidone in aggressive children and adolescents

Abstract

To date, no study has been published extensive monitoring of the use of risperidone in children and adolescents; however, references are appearing, more or less spacious and, in general, in shape of clinical cases, about its safety and efficacy in various disorders (other than schizophrenia) such as attention deficit hyperactivity disorder (jointly with methylphenidate), Tourette's disorder, pervasive developmental disorders and autism or disorder bipolar. The author describes his positive experience in 8 of 11 patients (ages 5 to age 16), classified as "one of the most behaviorally problematic "from his hospital.